174 related articles for article (PubMed ID: 35246054)
1. Lower bicarbonate level is associated with CKD progression and all-cause mortality: a propensity score matching analysis.
Fukasawa H; Kaneko M; Uchiyama Y; Yasuda H; Furuya R
BMC Nephrol; 2022 Mar; 23(1):86. PubMed ID: 35246054
[TBL] [Abstract][Full Text] [Related]
2. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
[TBL] [Abstract][Full Text] [Related]
3. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
4. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
[TBL] [Abstract][Full Text] [Related]
5. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
[TBL] [Abstract][Full Text] [Related]
6. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
Chinnadurai R; Clarke NW; Kalra PA
BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
[TBL] [Abstract][Full Text] [Related]
7. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
[TBL] [Abstract][Full Text] [Related]
9. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
[TBL] [Abstract][Full Text] [Related]
10. Low Serum Bicarbonate and CKD Progression in Children.
Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
[TBL] [Abstract][Full Text] [Related]
11. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
[TBL] [Abstract][Full Text] [Related]
12. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
[TBL] [Abstract][Full Text] [Related]
13. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
[TBL] [Abstract][Full Text] [Related]
14. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
[TBL] [Abstract][Full Text] [Related]
15. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease.
Raphael KL; Zhang Y; Ying J; Greene T
Nephrology (Carlton); 2014 Oct; 19(10):648-54. PubMed ID: 25066359
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study.
Kuo CC; Yeh HC; Chen B; Tsai CW; Lin YS; Huang CC
Medicine (Baltimore); 2015 Dec; 94(51):e2175. PubMed ID: 26705203
[TBL] [Abstract][Full Text] [Related]
18. Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N
Nephrol Dial Transplant; 2023 May; 38(6):1448-1458. PubMed ID: 36331426
[TBL] [Abstract][Full Text] [Related]
19. Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease.
Tanemoto M; Kamachi R; Kimura T; Yamada S; Yokoyama T; Okazaki Y
Clin Exp Nephrol; 2020 Dec; 24(12):1140-1143. PubMed ID: 32772208
[TBL] [Abstract][Full Text] [Related]
20. Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.
McDonald JS; McDonald RJ; Lieske JC; Carter RE; Katzberg RW; Williamson EE; Kallmes DF
Mayo Clin Proc; 2015 Aug; 90(8):1046-53. PubMed ID: 26250726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]